As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
To assess toxicity, Medicilon offers a wide range of GLP and non-GLP toxicology services. GLP and non-GLP Toxicology studies are required to determine the adverse effects of drug candidates and the effect of dosage on toxicity.
Late-Stage Discovery Studies
Maximum Tolerated Dose Studies (MTD)
Dose Range Finding Study
hERG – Ion Channel Screening
Exploratory Toxicology Study (7-day non-GLP Studies with PK)
GLP Toxicology Studies
7-day Repeat Dose Study (GLP)
14-day Repeat Dose Study (GLP)
21-day Repeat Dose Study (GLP)
3-month Chronic Repeat Dose Study (GLP)
6-month Chronic Repeat Dose Study (GLP)
9-month Chronic Repeat Dose Study (GLP)
Carcinogenicity Studies (Transgenic & 2 year)
Safety Pharmacology Studies (GLP)
Cardiovascular Study (Telemetry or Piggy-backed)
Respiratory Study
Central Nervous System Study (CNS Study)
Genetic Toxicology (Genetox)
Ames Assay (non-GLP & GLP) CRO
Micronucleus Assay
Chromosomal Aberration Assay
With extensive experience in drug development, Medicilon staff is dedicated to helping you complete your project in a timely and efficient manner. In addition to Good Laboratory Practice (GLP) toxicology studies, Medicilon provides all aspects of the GLP process from design to regulatory support of your IND FDA submission. Our preclinical team has extensive experience in set-up and management of GLP animal toxicology studies and other experience across all facets of preclinical research, from identification, assessment and due diligence on new compounds to conduct of animal models.
Email : marketing@medicilon.com
Tel : +86 021 5859-1500
Tips : Above is part of GLP Toxicology Studies, GLP Toxicology and Toxicology Testing Labs. You can also CONTACT US with any question or enquiry you may have. We will be happy to discuss your needs in detail and design an appropriate plan of action.
New Drug Preclinical Toxicology Research
General Toxicology Study Service
Pharmacokinetic test / toxicokinetic test
Medicilon attended the 6th National Congress of Toxicology successfully in Guangzhou
Date: May 16-18, 2023
Location: South San Francisco
Booth: #7